Key result
Telmisartan controls BP, protects organs, and reduces cardiovascular disease and mortality in high-risk hypertensive patients.
Telmisartan is highlighted as an effective treatment for hypertension and metabolic syndrome, offering pleiotropic benefits and cardiovascular risk reduction.
Supports telmisartan in high-risk hypertension; leaves open dedicated outcome trials for confirmation.
The paper highlights the use of telmisartan, one of the currently available angiotensin receptor blockers, for the treatment of patients with hypertension, metabolic syndrome, and those at high cardiovascular risk. Telmisartan treatment allows blood pressure control, provides organ protection at different stages of the cardiovascular continuum, and reduces the risk of cardiovascular diseases and death. The additional properties and pleiotropic activity of the drug determines its wide range of applications in cardiology.
No takes yet. Share an insight, caveat, or question.
Подзолков et al. (2017) conducted a review in Hypertension, metabolic syndrome, and high cardiovascular risk. Telmisartan was evaluated. Telmisartan provides blood pressure control, organ protection, and reduces the risk of cardiovascular diseases and death in patients with hypertension and high cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: